Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APRE | BMY | AMGN | GILD | REGN |
| Company | Aprea Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.07 | 49.41 | 333.93 | 83.37 | 1,151.32 |
| High | 3.07 | 50.18 | 339.00 | 84.52 | 1,156.40 |
| Low | 2.86 | 48.78 | 331.00 | 82.76 | 1,137.64 |
| Last | 2.86 | 49.74 | 332.92 | 83.89 | 1,138.81 |
| Change | -0.15 | +0.25 | +0.12 | +0.84 | -7.94 |
| % Change | -4.98% | +0.51% | +0.04% | +1.01% | -0.69% |
| Volume | 11,200 | 7,771,400 | 1,366,700 | 9,199,399 | 328,000 |
| 20-Day Average Volume | 7,025 | 8,557,130 | 1,736,285 | 6,438,015 | 407,680 |
| Previous Close | 3.01 | 49.49 | 332.80 | 83.05 | 1,146.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.37 | 49.06 | 329.25 | 79.63 | 1,167.27 |
| 20-Day Raw Stochastic | 0.00% | 73.87% | 69.60% | 90.09% | 26.10% |
| 20-Day Relative Strength | 34.79% | 57.58% | 55.28% | 71.85% | 50.26% |
| Weighted Alpha | -46.64 | -9.39 | +25.51 | +18.22 | +39.19 |
| Today's Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 88% Sell | 24% Buy | 72% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.18% since 09/11/24 | +2.37% since 09/11/24 | +0.89% since 09/11/24 | +3.64% since 09/11/24 | -0.23% since 09/11/24 |
| Low | 2.86 on 09/18/24 | 47.76 on 09/12/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 1,127.20 on 09/12/24 |
| High | 3.50 on 09/12/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | -24.74% since 08/16/24 | +0.77% since 08/16/24 | +3.57% since 08/16/24 | +13.70% since 08/16/24 | -3.43% since 08/16/24 |
| Low | 2.86 on 09/18/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 1,113.24 on 09/11/24 |
| High | 3.86 on 08/22/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | -29.73% since 06/18/24 | +21.88% since 06/18/24 | +8.80% since 06/18/24 | +32.84% since 06/18/24 | +9.59% since 06/18/24 |
| Low | 2.86 on 09/18/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 1,011.67 on 07/03/24 |
| High | 4.34 on 06/25/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | -56.34% since 03/18/24 | -3.59% since 03/18/24 | +22.89% since 03/18/24 | +14.51% since 03/18/24 | +18.64% since 03/18/24 |
| Low | 2.86 on 09/18/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
| High | 6.88 on 03/19/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,345 | 100,321,184 | 178,525,568 | 103,468,096 | 126,355,776 |
| Shares Outstanding, K | 5,430 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
| Annual Sales | 580,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -14,290,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 560,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
| Last Quarter Net Income | -3,470,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
| 60-Month Beta | 1.04 | 0.46 | 0.61 | 0.18 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 08/12/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 08/08/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.49 | 18.02 | 17.69 | 30.01 |